Biomarkers in personalized medicine: discovery and delivery | Zendy

Ben T. Chaffey | Zendy; Angela Silmon | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Biomarkers in personalized medicine: discovery and delivery

Author(s) -

Ben T. Chaffey,

Angela Silmon

Publication year - 2016

Publication title -

the biochemist

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.126

H-Index - 7

eISSN - 1740-1194

pISSN - 0954-982X

DOI - 10.1042/bio03801043

Subject(s) - personalized medicine , precision medicine , clinical practice , medicine , data science , medical physics , computer science , computational biology , bioinformatics , pathology , biology , family medicine

The rapidly developing field of personalized or precision medicine is moving clinical practice towards a new paradigm centred on ‘right patient – right medication – right time'. Such information is obtained through analysis of biomarkers, usually specific proteins or DNA sequences. To expand the range of conditions in which a precision approach can be used, it is vital that new biomarkers continue to be discovered and qualified as having clinical utility. Once this is achieved, it is just as important that clinically validated assays to measure these biomarkers are made available to clinical groups to guide prescribing practice.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research